David Sinclair· PhD
The NAD booster at Metro biotech is most advanced, entering phase 2.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
The NAD booster at Metro biotech is most advanced, entering phase 2.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
metro biotech which is here in Massachusetts and they work on they've been working for five years on making nad precursor molecules that are better than these two that are available publicly and there are ways to improve them better by bioavailability better stability better efficacy and those are moving into the clinic as well